Dr. Reddy Laboratories (RDY)
Create an Alert
36.71
-0.27 -0.73%
NYSE
Jun 18, 8:00PM
BATS Real time
Currency in USD
Dr. Reddy Laboratories Return on Equity:
8.74% for Dec. 31, 2012Dr. Reddy Laboratories Historical Return on Equity Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 8.74% |
| Dec. 31, 2012 | 22.78% |
| Sept. 30, 2012 | 26.39% |
| June 30, 2012 | 25.87% |
| March 31, 2012 | 25.90% |
| Dec. 31, 2011 | 28.44% |
| Sept. 30, 2011 | 24.83% |
| June 30, 2011 | 24.97% |
| March 31, 2011 | 24.31% |
| Dec. 31, 2010 | 21.21% |
| Sept. 30, 2010 | 3.55% |
| June 30, 2010 | |
| March 31, 2010 | |
| Dec. 31, 2009 | |
| Sept. 30, 2009 | |
| June 30, 2009 | |
| March 31, 2009 | -8.72% |
| Dec. 31, 2008 | 10.87% |
| Sept. 30, 2008 | 3.61% |
| June 30, 2008 | 6.60% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
About Return on Equity (ROE)
Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).
ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.
Investors generally are interested in company's that have high, increasing returns on equity.
Learn More
RDY Return on Equity Benchmarks
| Companies | |
|---|---|
| Mylan | 18.44% |
| Akorn | 22.86% |
| Valeant Pharmaceuticals International | -3.46% |
RDY Return on Equity Rankings
| Overall |
75th percentile 4125 of 16770 |
| Sector |
84th percentile 216 of 1410 in Healthcare |
| Industry |
84th percentile 23 of 152 in Drug Manufacturers - Specialty & Generic |
RDY Return on Equity Range, Past 5 Years
| Minimum | -8.72% | Mar 2009 |
| Maximum | 28.44% | Dec 2011 |
| Average | 16.62% |
